RICHLAND, WA--(Marketwired - Jan 7, 2014) - IsoRay Inc. (NYSE MKT: ISR) (www.isoray.com), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, ...
RICHLAND, WA--(Marketwired - May 12, 2014) - IsoRay Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced Isoray ...
RICHLAND, Wash.--(BUSINESS WIRE)-- IsoRay, Inc. (Amex: ISR) announced today it has received final approval from the State of Washington Department of Health to manufacture its GliaSite® radiation ...
September 14, 2011 — The US Food and Drug Administration (FDA) has cleared a radiation therapy system (GliaSite, IsoRay) for the delivery of brachytherapy in brain cancer patients. The catheter has a ...
IsoRay, Inc. (Amex: ISR) announced today that it has completed a license agreement with Hologic, Inc. (NASDAQ:HOLX) for exclusive worldwide distribution rights to the GliaSite® radiation therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results